Several previous reports have tried to identify predictive markers of response to nCRT, with some finding that pCR was associated with good tumor differentiation, a small tumor diameter, early T and N stage on imaging, low levels of pretreatment CEA and KRAS mutations [39]. This evidence concerns the gene KRAS and neoplasm.